The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
Newsweek on MSN9d
People Aren't Using Ozempic 'Responsibly', Says DoctorSome people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
Elected officials are looking to expand access to weight loss drugs like Ozempic and Wegovy for low-income Virginians as part ...
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
HealthDay on MSN2d
2023 Saw Decline in BMI, Obesity Prevalence in the United StatesBody mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback